PhotoPharmics
PrivateLast Round
Series B
Extension
Apr 18, 2025
Total Funding Raised
$22.64M
Company Overview
PhotoPharmics operates in Healthcare & Life Sciences and is based in Lehi, Utah. Its latest recorded funding round was a Series B Extension round in April 2025.
PhotoPharmics is a clinical-stage medical device company developing next-generation photo-neuromodulation therapies for neurodegenerative disorders, with an initial focus on Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PhotoPharmics Comparables
Compare PhotoPharmics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gondola Medical Technologies | 79% | |
| Cala Health | 79% | |
| Vielight Inc. | 78% |
For institutional investors. Book with your work email.
PhotoPharmics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 18, 2025 | ||||
| Series B | Nov 15, 2023 | ||||
| Grant | Sep 24, 2021 | ||||
| Series B | Apr 29, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PhotoPharmics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Frazier Group | Series B |
| Vectra Management Group | Series B |
| NIH RADx | Grant |
| Kickstart | Series B Extension, Series B |
| Angel Star Ventures | Series B |
| Frazier VC | Convertible Debt, Seed |
| National Institute on Drug Abuse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 36% MoM.
- Oct 3, 2025
Attending the 2025 International Congress of Parkinson's Disease and Movement Disorders.
For institutional investors. Book with your work email.
PhotoPharmics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PhotoPharmics's valuation, stock price, and market status.
Is PhotoPharmics a public or private company?
PhotoPharmics is a private company.
What is the current stock price of PhotoPharmics?
PhotoPharmics is a private company, so its shares have no public market price. Caplight tracks PhotoPharmics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PhotoPharmics worth (valuation)?
Valuation information for PhotoPharmics is not publicly available.
Can I buy PhotoPharmics stock?
PhotoPharmics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PhotoPharmics's last funding round?
PhotoPharmics's most recent funding round was Series B Extension on April 18, 2025.
Who are the main investors in PhotoPharmics?
Key investors in PhotoPharmics include Kickstart.
Will PhotoPharmics IPO soon?
No public IPO plans have been announced for PhotoPharmics.
How can I track PhotoPharmics secondary market activity?
Caplight tracks bids, offers, and trades in PhotoPharmics's shares on secondary markets.